Robert I. Goldfarb - Apr 1, 2023 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Role
Chief Operating Officer
Signature
Robert I. Goldfarb
Stock symbol
NXEN
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/3/2023, 10:23 AM
Previous filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common Stock Award +250K +14.06% 2.03M Apr 1, 2023 Direct F1
transaction NXEN Common Stock Award +250K +12.33% 2.28M Jul 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXEN Options to purchase common stock (right to buy) Award +1M 1M Aug 19, 2020 Common Stock 1M $0.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.